Letter from Pr Henri Joyeux no 150
This new letter explains to you how depression will be treated better with transdermal administration of the 2 pineal sleep and wake hormones.
We are embarking on a new therapeutic course.
We are already well aware of the obstacles that await us. We do not fear them, because they are in service of the general public.
French physicians are the world champions of prescribing antidepressants. Beyond this excessive prescribing, undoubtedly encouraged by pharmaceutical Laboratories, they should know that, on the pretext of helping patients sleep better, soporific and anxiolytic medicines, i.e. benzodiazepines and related drugs (such as Stilnox®), should never be prescribed to a patient taking antidepressants.
Antidepressants and sleeping pills are incompatible.
No one will be surprised by this, since the health authorities have just classified Zolpidem (Stilnox® and its generics), without also knowing why, in the category of narcotics. However, all narcotics are psychostimulant medicines that, by increasing vigilance and anxiety, maintain and promote nervous breakdowns.
Through Pr Jean-Bernard Fourtillan’s answers you will learn:
– The mechanism of nervous breakdowns, which can be compared to transient sleep disorders.
– By what mechanisms the various types of antidepressants (NRI and SRI) act.
– The characteristics of an ideal antidepressant treatment that does not disturb the sleep-wake cycle and has no undesirable effects.
– Why the dual-compartment transdermal patch, which will separately contain the 2 natural sleep and wake hormones, will constitute the ideal and most natural treatment for nervous breakdown.
– Why Alzheimer’s and Parkinson’s patients have nervous breakdowns, particularly when they learn of the disease of which they are victims.
– When the transdermal patch will be made available to patients.